WST (WST)
WST Revenue 2008–2025
WST annual/quarterly revenue history and growth rate from 2008 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- WST revenue for the quarter ending March 31, 2026 was 844.9 M, a 21.05% increase year-over-year.
- WST revenue for the twelve months ending March 31, 2026 was 3.1 B, a 7.68% increase year-over-year.
- WST annual revenue for 2025 was 3.1 B, a 6.25% increase from 2024.
- WST annual revenue for 2024 was 2.9 B, a 1.92% decrease from 2023.
- WST annual revenue for 2023 was 2.9 B, a 2.18% increase from 2022.
- WST annual revenue for 2022 was 2.9 B.
Revenue
TRAILING 12 MONTHS · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
West Pharmaceutical Services, Inc. (WST) — Frequently Asked Questions
West Pharmaceutical Services, Inc. (WST) is a publicly traded US company. In fiscal 2025 it reported revenue of $3.07B and net income of $494M. Explore WST's stock price, financial statements, earnings history, margins and key ratios below.
How much revenue does West Pharmaceutical Services, Inc. make?
West Pharmaceutical Services, Inc. reported revenue of $3.07B in fiscal 2025.
Is WST profitable?
In fiscal 2025, West Pharmaceutical Services, Inc. reported net income of $494M.